Cargando…
Prodrugs in Cardiovascular Therapy
Prodrugs are biologically inactive derivatives of an active drug intended to solve certain problems of the parent drug such as toxicity, instability, minimal solubility and non-targeting capabilities. The majority of drugs for cardiovascular diseases undergo first-pass metabolism, resulting in drug...
Autores principales: | Sandros, Marinella G., Sarraf, Chady B., Tabrizian, Maryam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245309/ https://www.ncbi.nlm.nih.gov/pubmed/18560335 http://dx.doi.org/10.3390/molecules13051156 |
Ejemplares similares
-
Zeptomole Detection of C-Reactive Protein in Serum by a Nanoparticle Amplified Surface Plasmon Resonance Imaging Aptasensor
por: Vance, Stephen A., et al.
Publicado: (2014) -
Prodrugs and prodrug-activated systems in gene therapy
por: Sheikh, Semira, et al.
Publicado: (2021) -
Prodrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy)
por: Denny, William A
Publicado: (2003) -
Functionalization of gadolinium metallofullerenes for detecting atherosclerotic plaque lesions by cardiovascular magnetic resonance
por: Dellinger, Anthony, et al.
Publicado: (2013) -
Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays
por: Vance, Stephen, et al.
Publicado: (2016)